1391 Results

People

  1. Vickers
    Vickers
  2. Adusumilli
    Adusumilli
  3. Marghoob
    Marghoob
  4. Scordo
    Scordo
  5. Levine
    Levine
  6. Saltz
    Saltz
  7. Cheung
    Cheung
  8. Ladanyi
    Ladanyi
  9. Lee
    Lee
  10. Abramson
    Abramson

Groups

  1. Department of Medicine (456)
  2. Surgery (266)
  3. Survivorship Research (205)
  4. Population Sciences Research Program (201)
  5. Solid Tumor Oncology Division (179)
  6. Center for Hematologic Malignancies (171)
  7. Epidemiology and Biostatistics (171)
  8. Hematologic Malignancies, Division of (170)
  9. GSK Faculty (152)
  10. Division of Subspecialty Medicine (146)
  1. "letter"
Formats
  1. Journal Article (990)
  2. Correspondence (221)
  3. Research Letter (168)
  4. Editorial (10)
  5. Miscellaneous (1)
  6. Review (1)
Groups
  1. Department of Medicine (456)
  2. Surgery (266)
  3. Survivorship Research (205)
  4. Population Sciences Research Program (201)
  5. Solid Tumor Oncology Division (179)
  6. Center for Hematologic Malignancies (171)

More Groups

People
  1. Andrew Vickers (46)
  2. Ashfaq Marghoob (18)
  3. Michael Scordo (18)
  4. Peter Bach (18)
  5. Prasad Adusumilli (18)
  6. Leonard Saltz (17)

More People

Years
  1. 2025 (45)
  2. 2024 (105)
  3. 2023 (67)
  4. 2022 (63)
  5. 2021 (32)
  6. 2020 (69)

More Years

Publications
  1. Journal of Clinical Oncology (118)
  2. New England Journal of Medicine (92)
  3. International Journal of Radiation Oncology, Biology, Physics (50)
  4. European Urology (33)
  5. JNCI: Journal of the National Cancer Institute (32)
  6. Leukemia and Lymphoma (32)

More Publications

Publishers
  1. Elsevier Inc. (154)
  2. Elsevier Science, Inc. (130)
  3. American Society of Clinical Oncology (120)
  4. Nature Publishing Group (98)
  5. Lippincott Williams & Wilkins (95)
  6. Massachusetts Medical Society (92)

More Publishers

Results (1391)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reply to Ilias Giannakodimos’ letter to the editor re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transperineal versus transrectal magnetic resonance imaging-targeted and systematic prostate biopsy to prevent infectious complications: The PREVENT randomized trial. Eur Urol. 2024;86:61–68
    Correspondence

    Hu, J. C.; Schaeffer, E. M.; Vickers, A. J.
    European Urology (2024)

    Fulltext@MSK | Save
  • Reply to Geoffrey H. Rosen, Nicholas H. Chakiryan, and Katie S. Murray's Letter to the Editor re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transperineal versus transrectal magnetic resonance imaging–targeted and systematic prostate biopsy to prevent infectious complications: The PREVENT randomized trial. Eur Urol. 2024;86:61–68
    Correspondence

    Hu, J. C.; Vickers, A. J.; Schaeffer, E. M.
    European Urology (2024)

    Fulltext@MSK | Save
  • Successful use of narsoplimab to treat allogeneic transplant-associated thrombotic microangiopathy while maintaining sirolimus
    Research Letter

    Alhomoud, M.; Scordo, M.; Perales, M. A.
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Comparative efficacy of carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) in newly-diagnosed multiple myeloma: A systematic review and meta-analysis
    Research Letter

    Costa, B. A.; Costa, T. A.; Pak, K.; Patel, A.; Felix, N.; Mouhieddine, T. H.; Richter, J.
    American Journal of Hematology (2024)

    Fulltext@MSK | Save
  • Reply to G.B. Mann et al and S. Sorscher
    Correspondence

    Jagsi, R.; Griffith, K. A.; Harris, E. E.; Wright, J. L.; Recht, A.; Taghian, A. G.; Lee, L.; Moran, M. S.; Small, W. Jr; Johnstone, C.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Improved CNS control with the addition of chemotherapy to osimertinib: A devil's bargain?
    Correspondence

    Yu, Y.; Miao, E.; Pike, L. R. G.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • To keep his arm “flying” high, omit consolidation radiation therapy
    Correspondence

    Figura, N. B.; Imber, B. S.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma
    Research Letter

    Zinzani, P. L.; Salles, G.; Moskowitz, A. J.; Santoro, A.; Mehta, A.; Barr, P. M.; Mehta-Shah, N.; Collins, G. P.; Ansell, S. M.; Brody, J. D.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Supportive oncodermatology practices in Europe and the USA
    Research Letter

    Freites-Martinez, A.; Apalla, Z.; Fattore, D.; Fida, M.; Bang, A. S.; Smith, J.; Babakoohi, S.; Lacouture, M.; Sibaud, V.
    Journal of the European Academy of Dermatology and Venereology (2024)

    Fulltext@MSK | Save
  • BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation
    Research Letter

    Stuver, R.; Mian, A.; Brown, S.; Devlin, S.; Caimi, P. F.; Chinapen, S.; Dahi, P.; Dean, R.; Epstein-Peterson, Z. D.; Hill, B.; more...
    American Journal of Hematology (2024)

    Fulltext@MSK | Save